RxDoctor Payments Data

Lisa Jenkins Haynie, MD

Family Medicine · White Stone, VANPI 1811975162

Payments from drug & device makers

$146in general payments, 2019–2025

Across 8 payments — averaging $18.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$51
  • Lilly USA, LLC$27
  • Astellas Pharma US Inc$18
  • Genentech USA, Inc.$15
  • Amarin Pharma, Inc.$13
  • AstraZeneca$12
  • plus $11 from 1 others

What the payments were for

  • Food & beverage$146100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$146 in reported general payments places this provider in the 35th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$160,275
Medicare patients
302
Services billed
3,641

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban92$78,567
JardianceEmpagliflozin31$28,392
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$14,909
EntrestoSacubitril/Valsartan15$11,224
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr14$10,160
MyrbetriqMirabegron21$8,993
FarxigaDapagliflozin Propanediol11$6,293
Janumet XrSitagliptin Phos/Metformin Hcl13$4,161
Tiotropium Bromide18$4,156
SynthroidLevothyroxine Sodium36$4,131
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$3,325
Wixela InhubFluticasone Propion/Salmeterol21$3,035
Albuterol Sulfate HfaAlbuterol Sulfate116$3,032
Atorvastatin Calcium386$2,829
Fluticasone-SalmeterolFluticasone Propion/Salmeterol19$1,996

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$11$78,56792 claims
Astellas Pharma US IncMyrbetriq$18$8,99321 claims
AstraZenecaFarxiga$12$6,29311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in White Stone

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →